Amryt receives orphan drug designation from the fda for mycapssa® (oral octreotide) for the treatment of carcinoid syndrome

Amryt receives orphan drug designation from the fda for mycapssa® (oral octreotide) for the t reatment of c arcinoid s y ndrome

AMYT Ratings Summary

AMYT Quant Ranking